NCT06365034View on ClinicalTrials.gov

Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma

RecruitingOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

January 31, 2025

Conditions
Carcinoma, Hepatocellular
Trial Locations (1)

250000

RECRUITING

the Qianfoshan Hospital, Jinan

All Listed Sponsors
lead

Qianfoshan Hospital

OTHER